Evidence map›Paper›PMID 36010662›Full record

ArticleCells2022

Transcriptional Response of Blood Mononuclear Cells from Patients with Inflammatory and Autoimmune Disorders Exposed to "Krakow Smog".

Adrianna Gałuszka-Bulaga, Jacek Hajto, Małgorzata Borczyk, Sławomir Gołda, Marcin Piechota, Michał Korostyński, Magdalena Rutkowska-Zapała, Paweł Latacz, Zofia Guła, Mariusz Korkosz and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Adrianna Gałuszka-BulagaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Jacek HajtoLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.ORCID 0000-0002-7103-4246
Małgorzata BorczykLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.
Sławomir GołdaLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.
Marcin PiechotaLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.ORCID 0000-0003-2468-151X
Michał KorostyńskiLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.ORCID 0000-0002-4273-7401
Magdalena Rutkowska-ZapałaDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Paweł LataczDepartment of Clinical Neurology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Zofia GułaDepartment of Rheumatology and Immunology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Mariusz KorkoszDepartment of Rheumatology and Immunology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Joanna PeraDepartment of Clinical Neurology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Agnieszka SłowikDepartment of Clinical Neurology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Maciej SiedlarDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.ORCID 0000-0002-3904-5412
Jarek BaranDepartment of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.ORCID 0000-0003-1787-1972
Jagiellonian University · PLMaj Institute of Pharmacology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the general awareness of the need to reduce air pollution, the efforts were undertaken in Poland to eliminate the pollutants and their harmful effect on human health seem to be insufficient. Moreover, the latest data indicate that the city of Krakow is at the forefront of the most polluted cities worldwide. Hence, in this report, we investigated the impact of particulate matter isolated from the air of Krakow (PM KRK) on the gene expression profile of peripheral blood mononuclear cells (PBMCs) in healthy donors (HD) and patients with atherosclerosis (AS), rheumatoid arthritis (RA) and multiple sclerosis (MS), after in vitro exposure. Blood samples were collected in two seasons, differing in the concentration of PM in the air (below or above a daily limit of 50 µg/m

Indexed as

Air PollutantsAutoimmune DiseasesHumansLeukocytes, MononuclearParticle SizeSmogAir PollutantsSmogair pollutionautoimmune disordersgene expressioninflammatory

Identifiers

PMID36010662
PMCPMC9406644
OpenAlexW4292546431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.